112 related articles for article (PubMed ID: 19435426)
1. Involvement of high mobility group B proteins in cisplatin-induced cytotoxicity in squamous cell carcinoma of skin.
Sharma A; Ramanjaneyulu A; Ray R; Rajeswari MR
DNA Cell Biol; 2009 Jul; 28(7):311-8. PubMed ID: 19435426
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin.
Sharma A; Ray R; Rajeswari MR
Cancer Invest; 2008 Oct; 26(8):843-51. PubMed ID: 18798064
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group A1 (HMGA1) protein expression correlates with cisplatin-induced cell death in squamous cell carcinoma of skin.
Sharma A; Ray R; Rajeswari MR
Cancer Invest; 2010 May; 28(4):340-9. PubMed ID: 19916743
[TBL] [Abstract][Full Text] [Related]
4. Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.
Krynetskaia NF; Phadke MS; Jadhav SH; Krynetskiy EY
Mol Cancer Ther; 2009 Apr; 8(4):864-72. PubMed ID: 19372559
[TBL] [Abstract][Full Text] [Related]
5. High mobility group box (HMGB) proteins of Plasmodium falciparum: DNA binding proteins with pro-inflammatory activity.
Kumar K; Singal A; Rizvi MM; Chauhan VS
Parasitol Int; 2008 Jun; 57(2):150-7. PubMed ID: 18234548
[TBL] [Abstract][Full Text] [Related]
6. Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma.
Claerhout S; Verschooten L; Van Kelst S; De Vos R; Proby C; Agostinis P; Garmyn M
Int J Cancer; 2010 Dec; 127(12):2790-803. PubMed ID: 21351258
[TBL] [Abstract][Full Text] [Related]
7. Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line.
Choi J; Lee MK; Oh KH; Kim YS; Choi HY; Baek SK; Jung KY; Woo JS; Lee SH; Kwon SY
Tumori; 2011; 97(2):196-202. PubMed ID: 21617715
[TBL] [Abstract][Full Text] [Related]
8. mTOR inhibitor rapamycin alone or combined with cisplatin inhibits growth of esophageal squamous cell carcinoma in nude mice.
Hou G; Zhang Q; Wang L; Liu M; Wang J; Xue L
Cancer Lett; 2010 Apr; 290(2):248-54. PubMed ID: 19853373
[TBL] [Abstract][Full Text] [Related]
9. HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases.
Zheng X; Lu J; Liu J; Zhou L; He Y
Biomed Pharmacother; 2023 Sep; 165():115118. PubMed ID: 37437373
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma.
Kondo K; Yamasaki S; Sugie T; Teratani N; Kan T; Imamura M; Shimada Y
Int J Cancer; 2006 Jan; 118(1):230-42. PubMed ID: 16003725
[TBL] [Abstract][Full Text] [Related]
11. In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin.
Momekov GTs; Ugrinova I; Pasheva EA; Bakalova AG; Varbanov HP; Ferdinandov DV; Ivanov DS; Konstantinov SM
Ann N Y Acad Sci; 2009 Aug; 1171():649-58. PubMed ID: 19723116
[TBL] [Abstract][Full Text] [Related]
12. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.
Arienti C; Zoli W; Pignatta S; Carloni S; Paganelli G; Ulivi P; Romeo A; Menghi E; Sarnelli A; Medri L; Polico R; Silvestrini R; Tesei A
J Cell Physiol; 2014 Oct; 229(10):1548-56. PubMed ID: 24591063
[TBL] [Abstract][Full Text] [Related]
14. GROβ and its downstream effector EGR1 regulate cisplatin-induced apoptosis in WHCO1 cells.
Dong Q; Zhang J; Hendricks DT; Zhao X
Oncol Rep; 2011 Apr; 25(4):1031-7. PubMed ID: 21271225
[TBL] [Abstract][Full Text] [Related]
15. High mobility group proteins stimulate DNA cleavage by apoptotic endonuclease DFF40/CAD due to HMG-box interactions with DNA.
Kalinowska-Herok M; Widłak P
Acta Biochim Pol; 2008; 55(1):21-6. PubMed ID: 18239742
[TBL] [Abstract][Full Text] [Related]
16. High mobility group B2 is secreted by myeloid cells and has mitogenic and chemoattractant activities similar to high mobility group B1.
Pusterla T; de Marchis F; Palumbo R; Bianchi ME
Autoimmunity; 2009 May; 42(4):308-10. PubMed ID: 19811285
[TBL] [Abstract][Full Text] [Related]
17. Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy response.
Wang Y; Li XP; Yin JY; Zhang Y; He H; Qian CY; Chen J; Zheng Y; Smieszkol K; Fu YL; Chen ZY; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):408-15. PubMed ID: 24684392
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
20. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
